← All indications
Bone Marrow Diseases
Diseases involving the BONE MARROW.
Subtype terms (5)
More specific conditions that are subtypes of Bone Marrow Diseases in the MeSH hierarchy.
- Bone Marrow Failure Disorders
50 drugs (33 approved, 17 experimental)
- Bone Marrow Neoplasms
2 drugs experimental
- Myelodysplastic-Myeloproliferative Diseases
58 drugs (41 approved, 17 experimental)
- Myelodysplastic Syndromes
750 drugs (272 approved, 478 experimental)
- Myeloproliferative Disorders
303 drugs (181 approved, 122 experimental)
Drugs by status
Phase 3 trials (15)
Phase 2 trials (20)
Phase 1 trials (18)
Other trials (2)
Organizations
Organization Involved with Phase 4 Indications (6)
Organization Involved with Phase 3 Indications (23)
- Daiichi Sankyo
- Amgen
- Il-Yang Pharm. Co., Ltd.
- Kyowa Hakko Kirin
- Qilu Pharmaceutical Co., Ltd.
- ZonMw: The Netherlands Organisation for Health Research and Development
- Medical Research Council
- National Cancer Institute (NCI)
- National Institute of Neurological Disorders and Stroke (NINDS)
- Canadian Cancer Trials Group
- Centre Henri Becquerel
- University of London
- University of Washington
- Seoul National University
- St. Marianna University School of Medicine
- University of Toronto
- Utrecht University
- University of Alberta
- University of Birmingham
- Fudan University
- University of Cambridge
- AO Foundation
- St. Jude Children's Hospital
Organization Involved with Phase 2 Indications (17)
- Scios
- Bristol-Myers Squibb
- Merck
- Bayer
- Cancer Trials Ireland
- Centre Hospitalier de la Région d'Annecy
- Hoosier Cancer Research Network
- The Adelaide and Meath Hospital
- Yonsei University
- Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie (ARTIC)
- Technion University
- University of Texas at Houston
- CH Annecy
- Washington University in St. Louis
- Innovative Therapies For Children with Cancer Consortium
- Dalian Merro Pharmaceutical Co. Ltd
- French Lung Cancer Group
Organization Involved with Phase 1 Indications (17)
- Celgene
- Eli Lilly
- Five Eleven Pharma, Inc.
- National Heart, Lung, and Blood Institute (NHLBI)
- Huazhong University of Science and Technology
- University of Arizona
- Harvard University
- Rutgers University
- University of Medicine and Dentistry of New Jersey
- University of Rochester
- Virginia Commonwealth University
- University of Utah
- Covance
- IQVIA
- KingMed Diagnostics
- Shanghai JMT-Bio Inc.
- Cellenkos, Inc.